Hong Kong Stock Market News:
1) Company News
$SIMCERE PHARMA (02096.HK)$Henlius has entered into a cooperation agreement with Tajiri on the drug TGRX-326 for non-small cell lung cancer.
According to the agreement, the subsidiary Simcere Zenming will obtain the exclusive commercial rights of TGRX-326 in mainland China. Tajiri will receive over 20 million US dollars as the upfront payment and will also pay promotion service fees to Simcere Zenming.
$TONGDAO LIEPIN (06100.HK)$Through its subsidiary, subscribed a total of 0.135 billion yuan in wealth management products.
$BAIC MOTOR (01958.HK)$The company has entered into a framework agreement with BAIC New Energy, and the company has conditionally agreed to subscribe for the shares to be issued by BAIC New Energy at approximately RMB 2.3815 per share. The total subscription price is RMB 2 billion.
$YUEXIU PROPERTY (00123.HK)$The company's Land Development Center, Guangzhou Xinxiu, and Guangzhou Construction have entered into a land acquisition agreement, under which Guangzhou Xinxin and Guangzhou Construction agree to transfer the land use rights of the land plot on the north side of Jinan University to the Land Development Center for a consideration of RMB 5.003 billion, and the compensation method is for the Land Development Center to provide equivalent payable notes to Guangzhou Xinxu and Guangzhou Construction.
$LC LOGISTICS (02490.HK)$Affiliated Bo Ya International Marine and Lecang Fantasy have entered into a framework agreement to acquire new ship order rights.
According to the announcement, Lecang Fantasy should transfer all rights and obligations under the shipbuilding agreement to Bo Ya International Marine in accordance with the replacement agreement, and Bo Ya International Marine should pay Lecang Fantasy a total price of $57.92 million, which is equivalent to the first installment payment that Lecang Fantasy has paid to China Ship Trade and Jiangnan Shipbuilding in accordance with the terms of the shipbuilding agreement.
$HENLIUS (02696.HK)$The clinical trial application for HLX17, a biosimilar of Pembrolizumab, has been approved by the National Medical Products Administration. In 2023, the sales of Pembrolizumab in China are expected to be approximately RMB 1.425 billion.
$SHANDONG XINHUA (00719.HK)$: Esomeprazole magnesium obtained the notice of approval for the listing application of chemical raw materials.
2) Repurchase Dynamics
$BABA-W (09988.HK)$: On August 30, it spent approximately $59.9767 million to repurchase 5.7592 million shares.
$TENCENT (00700.HK)$: It spent 1.003 billion Hong Kong dollars to repurchase 2.65 million shares, with a repurchase price of HKD 376.6-383.2.
$HSBC HOLDINGS (00005.HK)$Invested 0.315 billion Hong Kong dollars to repurchase 4.586 million shares, with a repurchase price of 67.95-68.9 Hong Kong dollars.
$AIA (01299.HK)$Invested 60.9982 million Hong Kong dollars to repurchase 1.11 million shares, with a repurchase price of 54.50-55.65 Hong Kong dollars.
$KUAISHOU-W (01024.HK)$Invested approximately 49.925 million Hong Kong dollars to repurchase 1.258 million shares, with a repurchase price of 39.45-39.95 Hong Kong dollars.
$MEITUAN-W (03690.HK)$Invested 15.2045 million Hong Kong dollars to repurchase 0.1313 million shares.
Focus on hotspots:
The Ministry of Industry and Information Technology: Implementing large-scale equipment digital transformation and upgrading.
In order to implement the deployment of the National Conference on the Promotion of the New Industrialization and the Action Plan for the Digital Transformation of Manufacturing Industry by the General Office of the State Council, and to continue to deepen the digitalization of the consumer goods industry to help the "Three Products" action, and accelerate the promotion of the digital transformation of the light industry and the integration of the internet, the Consumer Goods Industry Department of the Ministry of Industry and Information Technology has drafted the Implementation Plan for the Digital Transformation of the Light Industry (Draft for Soliciting Opinions).
HKEX will launch a weekly series of stock options, trading starts on November 4th.
HKEX will launch a weekly stock options series. The series has been approved by the Hong Kong Securities and Futures Commission and will be available for trading by market participants on November 4, 2024, once the market is ready.
The following stocks will have new options series added:$HSBC HOLDINGS (00005.HK)$and$HKEX (00388.HK)$N/A.$TENCENT (00700.HK)$,$KUAISHOU-W (01024.HK)$,$BYD COMPANY (01211.HK)$,$PING AN (02318.HK)$,$MEITUAN-W (03690.HK)$,$JD-SW (09618.HK)$,$BIDU-SW (09888.HK)$and$BABA-W (09988.HK)$.
According to the distribution data of bull and bear street warrants on the Societe Generale HSI, the heavy bear zone and the highest increase are in the range of 18200-18299. The latest number of bear warrants in this range is 761, an increase of 364 from the previous trading day.
The heavy bull zone and the highest increase of bull street warrants are in the range of 17400-17499. The latest number of bull warrants in this range is 1192, an increase of 588 from the previous trading day.
编辑/ping
Boosted by the subsidy for trade-in, Tesla's shipment volume in China increased year-on-year in August.
At the close of the night session of July 27th,
$HSI Futures Current Contract (HSIcurrent.HK)$
![](https://postimg.futunn.com/news-editor-imgs/20240903/public/17253189697336233128899.png)
Hang Seng Index Bull & Bear Certificates
![](https://postimg.futunn.com/news-editor-imgs/20240903/public/1725319084091123254223.jpeg)
Editor/ping